On February 5, 2026 AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, reported that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Guggenheim Emerging Outlook: Biotech Summit 2026, New York, NY
Format – Fireside chat and 1×1 investor meetings
Date and Time – Wednesday, Feb. 11, 2026 at 3:00pm ET
Piper Sandler Virtual Novel Targets in Immunology Symposium, Virtual
Format – Fireside chat
Date and Time – Thursday, Feb. 12, 2026 at 12:30pm ET
TD Cowen 46th Annual Health Care Conference, Boston, MA
Format – Fireside chat and 1×1 investor meetings
Date and Time – Wednesday, Mar. 4, 2026 at 11:50am ET
Barclays 28th Annual Global Healthcare Conference, Miami, FL
Format – Fireside chat and 1×1 investor meetings
Date and Time – Tuesday, Mar. 10, 2026 at 8:30am ET
UBS Biotech Summit Miami: Catalyst for Change, Miami, FL
Format –1×1 investor meetings
Date and Time – Tuesday, Mar. 10, 2026
Leerink Global Healthcare Conference, Miami FL
Format – Fireside chat and 1×1 investor meetings
Date and Time – Wednesday, Mar. 11, 2026 at 2:20pm ET
Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at View Source Replays of the webcasts will be available for at least 30 days following the events.
(Press release, AnaptysBio, FEB 5, 2026, View Source [SID1234662503])